EUVIMEDEUVIMED entdecken
Crossref

Evaluating the addition of real-time continuous glucose monitors to pharmacist intervention on glycated hemoglobin

Alexandra DeBoest, Chelsea Holley, Megan Hickey, Michael Kallenberger, Jeremy John, Matt Baker

American Journal of Health-System Pharmacy · 2025

DOI: 10.1093/ajhp/zxaf344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2025. Verfasst von Alexandra DeBoest und 5 weiteren Autor:innen. Beteiligte Einrichtung: NKC Health, North Kansas City, MO, USA. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Diabetes Mellitus, Type 2, Continuous Glucose Monitoring, Pharmacists. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To determine the impact of pharmacist intervention with real-time continuous glucose monitors (rtCGMs) on glycated hemoglobin (HbA1c) levels and the number of pharmacist touchpoints compared to standard of care (SOC).

Methods

Patients receiving care at a primary care clinic using an established pharmacist diabetes management protocol for patients with type 2 diabetes and an HbA1c value of 9% or higher despite taking basal insulin were included in this study. The SOC group comprised patients receiving ongoing care, while care for the rtCGM study group followed the same protocol with addition of Dexcom G6 rtCGMs. Data on patient demographics, comorbidities, and medications were collected for comparison. The primary outcome was the between-group difference in changes in HbA1c. The secondary outcome was the difference in pharmacist touchpoints, quantified as the number of patient telephone calls completed and attempted, along with medication interventions.

Results

Fifty-seven patients were included in the final analysis: 30 in the SOC group who received pharmacist intervention and 27 in the combined pharmacist intervention and rtCGM group. The mean (SD) reduction in HbA1c in the SOC group at 90 days was 2.05% (1.20%) compared to 2.94% (1.18%) in the rtCGM group (P = 0.0165). The secondary outcome failed to reach statistical significance (P = 0.1413).

Conclusion

In suboptimally managed type 2 diabetes, augmentation of a standard diabetes management protocol with rtCGMs was associated with significantly greater HbA1c reduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinDiabetes Mellitus, Type 2Continuous Glucose MonitoringPharmacistsBlood GlucoseProfessional RoleHumansFemaleMaleAgedMiddle AgedHypoglycemic Agents

Stichwörter der Autor:innen

community healthcontinuous glucose monitoringdiabetes mellitusglycated hemoglobinpharmacy

Substanzen

Glycated HemoglobinBlood GlucoseHypoglycemic Agentshemoglobin A1c protein, human

Autor:innen und Institutionen

  • NKC Health, North Kansas City, MO, USA.

Zitieren

APA

DeBoest, A., Holley, C., Hickey, M., Kallenberger, M., John, J., & Baker, M. (2025). Evaluating the addition of real-time continuous glucose monitors to pharmacist intervention on glycated hemoglobin. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxaf344

Vancouver

DeBoest A, Holley C, Hickey M, Kallenberger M, John J, Baker M. Evaluating the addition of real-time continuous glucose monitors to pharmacist intervention on glycated hemoglobin. American Journal of Health-System Pharmacy. 2025. doi:10.1093/ajhp/zxaf344

BibTeX
@article{DeBoest2025,
  author = {DeBoest, Alexandra and Holley, Chelsea and Hickey, Megan and Kallenberger, Michael and John, Jeremy and Baker, Matt},
  title = {Evaluating the addition of real-time continuous glucose monitors to pharmacist intervention on glycated hemoglobin},
  journal = {American Journal of Health-System Pharmacy},
  year = {2025},
  doi = {10.1093/ajhp/zxaf344}
}
Kostenlos starten →